Glucose transporter Glut-1 is detectable in pen-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays

Article English OPEN
Airley, R; Evans, AR; Mobasheri, A; Hewitt, SM;

The hypoxic tumor microenvironment is associated with malignant progression and poor treatment response. The glucose transporter Glut-1 is a prognostic factor and putative hypoxia marker. So far, studies of Glut-1 in cancer have utilised conventional immunohistochemical... View more
  • References (18)
    18 references, page 1 of 2

    Ahmed, N., Berridge, M.V., 1997. Regulation of glucose transport by interleukin-3 in growth factordependent and oncogene-transformed bone marrow-derived cell lines. Leuk Res. 21, 609-618.

    Airley, R., Loncaster, J., Davidson, S., Bromley, M., Roberts, S., Patterson, A., Hunter, R., Stratford, I., West, C., 2001. Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin Cancer Res. 7, 928-934.

    Airley, R.E., Loncaster, J., Raleigh, J.A., Harris, A.L., Davidson, S.E., Hunter, R.D., West, C.M., Stratford, I.J., 2003. GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding. Int J Cancer. 104, 85-91.

    Airley, R.E., Phillips, R.M., Evans, A.E., Double, J., Burger, A.M., Feibig, H.H., West, C.M., Stratford, I.J., 2005. Hypoxia-regulated glucose transporter Glut-1 may influence chemosensitivity to some alkylating agents: results of EORTC (First Translational Award) study of the relevance of tumour hypoxia to the outcome of chemotherapy in human tumour-derived xenografts. Int J Oncol. 26, 1477-1484.

    Albertella, M.R., Loadman, P.M., Jones, P.H., Phillips, R.M., Rampling, R., Burnet, N., Alcock, C., Anthoney, A., Vjaters, E., Dunk, C.R., Harris, P.A., Wong, A., Lalani, A.S., Twelves, C.J., 2008. Hypoxia-selective targeting by the bioreductive prodrug AQ4N in patients with solid tumors: results of a phase I study. Clin Cancer Res. 14, 1096-1104.

    Amann, T., Maegdefrau, U., Hartmann, A., Agaimy, A., Marienhagen, J., Weiss, T.S., Stoeltzing, O., Warnecke, C., Scholmerich, J., Oefner, P.J., Kreutz, M., Bosserhoff, A.K., Hellerbrand, C., 2009. GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. Am J Pathol. 174, 1544-1552.

    Baron-Delage, S., Mahraoui, L., Cadoret, A., Veissiere, D., Taillemite, J.L., Chastre, E., Gespach, C., Zweibaum, A., Capeau, J., Brot-Laroche, E., Cherqui, G., 1996. Deregulation of hexose transporter expression in Caco-2 cells by ras and polyoma middle T oncogenes. Am J Physiol. 270, G314-323.

    Behrooz, A., Ismail-Beigi, F., 1997. J Biol Chem. 272, 5555-5562.

    Binder, C., Binder, L., Marx, D., Schauer, A., Hiddemann, W., 1997. Deregulated simultaneous expression of multiple glucose transporter isoforms in malignant cells and tissues. Anticancer Res. 17, 4299- 4304.

    Brizel, D.M., Scully, S.P., Harrelson, J.M., Layfield, L.J., Bean, J.M., Prosnitz, L.R., Dewhirst, M.W., 1996. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56, 941-943.

  • Related Organizations (1)
  • Metrics
Share - Bookmark